Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Operating Expenses | 9,744 | 15,290 | 16,919 | 20,237 | 19,369 |
| Operating Income | -9,744 | -15,290 | -16,919 | -20,237 | -19,369 |
| Interest Expense | 98 | 161 | 222 | 389 | 260 |
| Other Income | 795 | -1,276 | 100 | 822 | -134 |
| Pre-tax Income | -9,047 | -16,727 | -17,041 | -19,804 | -19,763 |
| Net Income Continuous | -9,047 | -16,727 | -17,041 | -19,804 | -19,763 |
| Minority Interests | -80 | -65 | -44 | -70 | -45 |
| Net Income | $-8,967 | $-16,662 | $-16,997 | $-19,734 | $-19,718 |
| EPS Basic Total Ops | -2.80 | -8.00 | -7.00 | -17.50 | -13.20 |
| EPS Basic Continuous Ops | -1.82 | -4.52 | -5.15 | -6.76 | -6.89 |
| EPS Diluted Total Ops | -2.80 | -8.00 | -7.00 | -17.50 | -13.20 |
| EPS Diluted Continuous Ops | -1.82 | -4.52 | -5.15 | -6.76 | -6.89 |
| EBITDA(a) | $-9,081 | $-14,592 | $-16,313 | $-19,793 | $-18,940 |